Fugu (Takifugu rubripes) sexual differentiation: CYP19 regulation and aromatase inhibitor induced testicular development

H. Rashid, Hajime Kitano, K. Hoon Lee, S. Nii, T. Shigematsu, K. Kadomura, Akihiko Yamaguchi, Michiya Matsuyama

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In order to assess the involvement of aromatase CYP19 isoforms and endogenous sex steroids in gonadal sex differentiation and development of the Japanese fugu (Takifugu rubripes), an aromatase inhibitor (AI, fadrozole) was administered to developing fishes from the 'first feeding' till the 100th day after hatching. It was observed that ovarian cavity formation was inhibited by fadrozole at doses of 500 and 1000 μg/g diet, which was followed by testicular differentiation in all treated fugu. In the non-treated fugu, CYP19A was predominantly expressed in the ovary and CYP19B in the brain (in both sexes), although both were expressed interchangeably at low levels. An exceptionally high expression of CYP19B was also evident in testis throughout the study period. Both forms of CYP19 mRNA showed low levels of expression in brain and gonad with no significant differences between the two AI treatments. AI treatment inhibited CYP19A mRNA in trunk during the crucial period of ovarian cavity formation and CYP19B in gonad and brain by the end of gonadal sex differentiation. An elevation of testosterone and 11-ketotestosterone was observed which can be associated with the down-regulation of the circulating 17β-estradiol production during the AI treatment period. After stopping AI treatment, both circulating estrogen and androgen were normalized. The current results suggest that suppression of CYP19A before and during morphological sex differentiation inhibits ovarian cavity formation in fugu. Furthermore, non-detectable limits of 17β-estradiol and high testosterone levels by the end of the gonadal differentiation period can be ascribed to inhibition of CYP19B, suggesting that conversion of 17β-estradiol from testosterone is plausibly regulated by CYP19B, and that this factor (CYP19B) may play an important role in AI-induced testicular development after gonadal sex differentiation through regulation of the testosterone-17β-estradiol balance in fugu.

Original languageEnglish
Pages (from-to)311-322
Number of pages12
JournalSexual Development
Volume1
Issue number5
DOIs
Publication statusPublished - Nov 1 2007

Fingerprint

Takifugu
Sex Differentiation
Aromatase Inhibitors
Aromatase
Testosterone
Estradiol
Fadrozole
Gonads
Brain
Messenger RNA
Sexual Development
Androgens
Testis
Ovary
Protein Isoforms
Estrogens
Fishes
Down-Regulation
Steroids
Diet

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Embryology
  • Developmental Biology

Cite this

Fugu (Takifugu rubripes) sexual differentiation : CYP19 regulation and aromatase inhibitor induced testicular development. / Rashid, H.; Kitano, Hajime; Hoon Lee, K.; Nii, S.; Shigematsu, T.; Kadomura, K.; Yamaguchi, Akihiko; Matsuyama, Michiya.

In: Sexual Development, Vol. 1, No. 5, 01.11.2007, p. 311-322.

Research output: Contribution to journalArticle

Rashid, H. ; Kitano, Hajime ; Hoon Lee, K. ; Nii, S. ; Shigematsu, T. ; Kadomura, K. ; Yamaguchi, Akihiko ; Matsuyama, Michiya. / Fugu (Takifugu rubripes) sexual differentiation : CYP19 regulation and aromatase inhibitor induced testicular development. In: Sexual Development. 2007 ; Vol. 1, No. 5. pp. 311-322.
@article{cab1b77bf41b493fac9b9024971c7008,
title = "Fugu (Takifugu rubripes) sexual differentiation: CYP19 regulation and aromatase inhibitor induced testicular development",
abstract = "In order to assess the involvement of aromatase CYP19 isoforms and endogenous sex steroids in gonadal sex differentiation and development of the Japanese fugu (Takifugu rubripes), an aromatase inhibitor (AI, fadrozole) was administered to developing fishes from the 'first feeding' till the 100th day after hatching. It was observed that ovarian cavity formation was inhibited by fadrozole at doses of 500 and 1000 μg/g diet, which was followed by testicular differentiation in all treated fugu. In the non-treated fugu, CYP19A was predominantly expressed in the ovary and CYP19B in the brain (in both sexes), although both were expressed interchangeably at low levels. An exceptionally high expression of CYP19B was also evident in testis throughout the study period. Both forms of CYP19 mRNA showed low levels of expression in brain and gonad with no significant differences between the two AI treatments. AI treatment inhibited CYP19A mRNA in trunk during the crucial period of ovarian cavity formation and CYP19B in gonad and brain by the end of gonadal sex differentiation. An elevation of testosterone and 11-ketotestosterone was observed which can be associated with the down-regulation of the circulating 17β-estradiol production during the AI treatment period. After stopping AI treatment, both circulating estrogen and androgen were normalized. The current results suggest that suppression of CYP19A before and during morphological sex differentiation inhibits ovarian cavity formation in fugu. Furthermore, non-detectable limits of 17β-estradiol and high testosterone levels by the end of the gonadal differentiation period can be ascribed to inhibition of CYP19B, suggesting that conversion of 17β-estradiol from testosterone is plausibly regulated by CYP19B, and that this factor (CYP19B) may play an important role in AI-induced testicular development after gonadal sex differentiation through regulation of the testosterone-17β-estradiol balance in fugu.",
author = "H. Rashid and Hajime Kitano and {Hoon Lee}, K. and S. Nii and T. Shigematsu and K. Kadomura and Akihiko Yamaguchi and Michiya Matsuyama",
year = "2007",
month = "11",
day = "1",
doi = "10.1159/000108935",
language = "English",
volume = "1",
pages = "311--322",
journal = "Sexual Development",
issn = "1661-5425",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Fugu (Takifugu rubripes) sexual differentiation

T2 - CYP19 regulation and aromatase inhibitor induced testicular development

AU - Rashid, H.

AU - Kitano, Hajime

AU - Hoon Lee, K.

AU - Nii, S.

AU - Shigematsu, T.

AU - Kadomura, K.

AU - Yamaguchi, Akihiko

AU - Matsuyama, Michiya

PY - 2007/11/1

Y1 - 2007/11/1

N2 - In order to assess the involvement of aromatase CYP19 isoforms and endogenous sex steroids in gonadal sex differentiation and development of the Japanese fugu (Takifugu rubripes), an aromatase inhibitor (AI, fadrozole) was administered to developing fishes from the 'first feeding' till the 100th day after hatching. It was observed that ovarian cavity formation was inhibited by fadrozole at doses of 500 and 1000 μg/g diet, which was followed by testicular differentiation in all treated fugu. In the non-treated fugu, CYP19A was predominantly expressed in the ovary and CYP19B in the brain (in both sexes), although both were expressed interchangeably at low levels. An exceptionally high expression of CYP19B was also evident in testis throughout the study period. Both forms of CYP19 mRNA showed low levels of expression in brain and gonad with no significant differences between the two AI treatments. AI treatment inhibited CYP19A mRNA in trunk during the crucial period of ovarian cavity formation and CYP19B in gonad and brain by the end of gonadal sex differentiation. An elevation of testosterone and 11-ketotestosterone was observed which can be associated with the down-regulation of the circulating 17β-estradiol production during the AI treatment period. After stopping AI treatment, both circulating estrogen and androgen were normalized. The current results suggest that suppression of CYP19A before and during morphological sex differentiation inhibits ovarian cavity formation in fugu. Furthermore, non-detectable limits of 17β-estradiol and high testosterone levels by the end of the gonadal differentiation period can be ascribed to inhibition of CYP19B, suggesting that conversion of 17β-estradiol from testosterone is plausibly regulated by CYP19B, and that this factor (CYP19B) may play an important role in AI-induced testicular development after gonadal sex differentiation through regulation of the testosterone-17β-estradiol balance in fugu.

AB - In order to assess the involvement of aromatase CYP19 isoforms and endogenous sex steroids in gonadal sex differentiation and development of the Japanese fugu (Takifugu rubripes), an aromatase inhibitor (AI, fadrozole) was administered to developing fishes from the 'first feeding' till the 100th day after hatching. It was observed that ovarian cavity formation was inhibited by fadrozole at doses of 500 and 1000 μg/g diet, which was followed by testicular differentiation in all treated fugu. In the non-treated fugu, CYP19A was predominantly expressed in the ovary and CYP19B in the brain (in both sexes), although both were expressed interchangeably at low levels. An exceptionally high expression of CYP19B was also evident in testis throughout the study period. Both forms of CYP19 mRNA showed low levels of expression in brain and gonad with no significant differences between the two AI treatments. AI treatment inhibited CYP19A mRNA in trunk during the crucial period of ovarian cavity formation and CYP19B in gonad and brain by the end of gonadal sex differentiation. An elevation of testosterone and 11-ketotestosterone was observed which can be associated with the down-regulation of the circulating 17β-estradiol production during the AI treatment period. After stopping AI treatment, both circulating estrogen and androgen were normalized. The current results suggest that suppression of CYP19A before and during morphological sex differentiation inhibits ovarian cavity formation in fugu. Furthermore, non-detectable limits of 17β-estradiol and high testosterone levels by the end of the gonadal differentiation period can be ascribed to inhibition of CYP19B, suggesting that conversion of 17β-estradiol from testosterone is plausibly regulated by CYP19B, and that this factor (CYP19B) may play an important role in AI-induced testicular development after gonadal sex differentiation through regulation of the testosterone-17β-estradiol balance in fugu.

UR - http://www.scopus.com/inward/record.url?scp=36248971114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248971114&partnerID=8YFLogxK

U2 - 10.1159/000108935

DO - 10.1159/000108935

M3 - Article

C2 - 18391543

AN - SCOPUS:36248971114

VL - 1

SP - 311

EP - 322

JO - Sexual Development

JF - Sexual Development

SN - 1661-5425

IS - 5

ER -